Antihelminthics Industry Research Report 2025
Description
Summary
According to APO Research, the global Antihelminthics market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Antihelminthics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antihelminthics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Antihelminthics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Antihelminthics include Abbott, Sanofi, Sanofi, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer and AstraZeneca, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antihelminthics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antihelminthics.
The report will help the Antihelminthics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Antihelminthics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antihelminthics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Antihelminthics Segment by Company
Abbott
Sanofi
Sanofi
Johnson & Johnson
Novartis
Pfizer
GlaxoSmithKline
Bayer
AstraZeneca
ZEISS International
Merck & Co.
Mentis Pharma
Astellas Pharma
ALLERGAN
Antihelminthics Segment by Type
Salicylanilides
Benzimidazoles
Praziquantel
Abamectin
Other
Antihelminthics Segment by Application
Ascariasis
Giardiasis
Fasciolasis
Filariasis
Angiostrongylosis
Schistosomiasis
Other
Antihelminthics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antihelminthics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antihelminthics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antihelminthics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antihelminthics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antihelminthics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antihelminthics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Antihelminthics market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Antihelminthics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antihelminthics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Antihelminthics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Antihelminthics include Abbott, Sanofi, Sanofi, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer and AstraZeneca, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antihelminthics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antihelminthics.
The report will help the Antihelminthics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Antihelminthics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antihelminthics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Antihelminthics Segment by Company
Abbott
Sanofi
Sanofi
Johnson & Johnson
Novartis
Pfizer
GlaxoSmithKline
Bayer
AstraZeneca
ZEISS International
Merck & Co.
Mentis Pharma
Astellas Pharma
ALLERGAN
Antihelminthics Segment by Type
Salicylanilides
Benzimidazoles
Praziquantel
Abamectin
Other
Antihelminthics Segment by Application
Ascariasis
Giardiasis
Fasciolasis
Filariasis
Angiostrongylosis
Schistosomiasis
Other
Antihelminthics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antihelminthics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antihelminthics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antihelminthics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antihelminthics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antihelminthics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antihelminthics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
121 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antihelminthics Market Size (2020-2031)
- 2.2.2 Global Antihelminthics Sales (2020-2031)
- 2.2.3 Global Antihelminthics Market Average Price (2020-2031)
- 2.3 Antihelminthics by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Salicylanilides
- 2.3.3 Benzimidazoles
- 2.3.4 Praziquantel
- 2.3.5 Abamectin
- 2.3.6 Other
- 2.4 Antihelminthics by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Ascariasis
- 2.4.3 Giardiasis
- 2.4.4 Fasciolasis
- 2.4.5 Filariasis
- 2.4.6 Angiostrongylosis
- 2.4.7 Schistosomiasis
- 2.4.8 Other
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antihelminthics Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Antihelminthics Sales (K Units) of Manufacturers (2020-2025)
- 3.3 Global Antihelminthics Revenue of Manufacturers (2020-2025)
- 3.4 Global Antihelminthics Average Price by Manufacturers (2020-2025)
- 3.5 Global Antihelminthics Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Antihelminthics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antihelminthics, Product Type & Application
- 3.8 Global Manufacturers of Antihelminthics, Established Date
- 3.9 Global Antihelminthics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Abbott Antihelminthics Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Sanofi Antihelminthics Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 Sanofi Antihelminthics Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Johnson & Johnson
- 4.4.1 Johnson & Johnson Company Information
- 4.4.2 Johnson & Johnson Business Overview
- 4.4.3 Johnson & Johnson Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 Johnson & Johnson Antihelminthics Product Portfolio
- 4.4.5 Johnson & Johnson Recent Developments
- 4.5 Novartis
- 4.5.1 Novartis Company Information
- 4.5.2 Novartis Business Overview
- 4.5.3 Novartis Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 Novartis Antihelminthics Product Portfolio
- 4.5.5 Novartis Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 Pfizer Antihelminthics Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 GlaxoSmithKline
- 4.7.1 GlaxoSmithKline Company Information
- 4.7.2 GlaxoSmithKline Business Overview
- 4.7.3 GlaxoSmithKline Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 GlaxoSmithKline Antihelminthics Product Portfolio
- 4.7.5 GlaxoSmithKline Recent Developments
- 4.8 Bayer
- 4.8.1 Bayer Company Information
- 4.8.2 Bayer Business Overview
- 4.8.3 Bayer Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.8.4 Bayer Antihelminthics Product Portfolio
- 4.8.5 Bayer Recent Developments
- 4.9 AstraZeneca
- 4.9.1 AstraZeneca Company Information
- 4.9.2 AstraZeneca Business Overview
- 4.9.3 AstraZeneca Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.9.4 AstraZeneca Antihelminthics Product Portfolio
- 4.9.5 AstraZeneca Recent Developments
- 4.10 ZEISS International
- 4.10.1 ZEISS International Company Information
- 4.10.2 ZEISS International Business Overview
- 4.10.3 ZEISS International Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.10.4 ZEISS International Antihelminthics Product Portfolio
- 4.10.5 ZEISS International Recent Developments
- 4.11 Merck & Co.
- 4.11.1 Merck & Co. Company Information
- 4.11.2 Merck & Co. Business Overview
- 4.11.3 Merck & Co. Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.11.4 Merck & Co. Antihelminthics Product Portfolio
- 4.11.5 Merck & Co. Recent Developments
- 4.12 Mentis Pharma
- 4.12.1 Mentis Pharma Company Information
- 4.12.2 Mentis Pharma Business Overview
- 4.12.3 Mentis Pharma Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.12.4 Mentis Pharma Antihelminthics Product Portfolio
- 4.12.5 Mentis Pharma Recent Developments
- 4.13 Astellas Pharma
- 4.13.1 Astellas Pharma Company Information
- 4.13.2 Astellas Pharma Business Overview
- 4.13.3 Astellas Pharma Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.13.4 Astellas Pharma Antihelminthics Product Portfolio
- 4.13.5 Astellas Pharma Recent Developments
- 4.14 ALLERGAN
- 4.14.1 ALLERGAN Company Information
- 4.14.2 ALLERGAN Business Overview
- 4.14.3 ALLERGAN Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
- 4.14.4 ALLERGAN Antihelminthics Product Portfolio
- 4.14.5 ALLERGAN Recent Developments
- 5 Global Antihelminthics Market Scenario by Region
- 5.1 Global Antihelminthics Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Antihelminthics Sales by Region: 2020-2031
- 5.2.1 Global Antihelminthics Sales by Region: 2020-2025
- 5.2.2 Global Antihelminthics Sales by Region: 2026-2031
- 5.3 Global Antihelminthics Revenue by Region: 2020-2031
- 5.3.1 Global Antihelminthics Revenue by Region: 2020-2025
- 5.3.2 Global Antihelminthics Revenue by Region: 2026-2031
- 5.4 North America Antihelminthics Market Facts & Figures by Country
- 5.4.1 North America Antihelminthics Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Antihelminthics Sales by Country (2020-2031)
- 5.4.3 North America Antihelminthics Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Antihelminthics Market Facts & Figures by Country
- 5.5.1 Europe Antihelminthics Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Antihelminthics Sales by Country (2020-2031)
- 5.5.3 Europe Antihelminthics Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Antihelminthics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antihelminthics Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Antihelminthics Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Antihelminthics Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antihelminthics Market Facts & Figures by Country
- 5.7.1 South America Antihelminthics Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Antihelminthics Sales by Country (2020-2031)
- 5.7.3 South America Antihelminthics Revenue by Country (2020-2031)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Antihelminthics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antihelminthics Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Antihelminthics Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Antihelminthics Revenue by Country (2020-2031)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
- 6 Segment by Type
- 6.1 Global Antihelminthics Sales by Type (2020-2031)
- 6.1.1 Global Antihelminthics Sales by Type (2020-2031) & (K Units)
- 6.1.2 Global Antihelminthics Sales Market Share by Type (2020-2031)
- 6.2 Global Antihelminthics Revenue by Type (2020-2031)
- 6.2.1 Global Antihelminthics Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Antihelminthics Revenue Market Share by Type (2020-2031)
- 6.3 Global Antihelminthics Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Antihelminthics Sales by Application (2020-2031)
- 7.1.1 Global Antihelminthics Sales by Application (2020-2031) & (K Units)
- 7.1.2 Global Antihelminthics Sales Market Share by Application (2020-2031)
- 7.2 Global Antihelminthics Revenue by Application (2020-2031)
- 7.2.1 Global Antihelminthics Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Antihelminthics Revenue Market Share by Application (2020-2031)
- 7.3 Global Antihelminthics Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antihelminthics Value Chain Analysis
- 8.1.1 Antihelminthics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antihelminthics Production Mode & Process
- 8.2 Antihelminthics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antihelminthics Distributors
- 8.2.3 Antihelminthics Customers
- 9 Global Antihelminthics Analyzing Market Dynamics
- 9.1 Antihelminthics Industry Trends
- 9.2 Antihelminthics Industry Drivers
- 9.3 Antihelminthics Industry Opportunities and Challenges
- 9.4 Antihelminthics Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Antihelminthics Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
- Table 6. Global Antihelminthics Sales (K Units) of Manufacturers (2020-2025)
- Table 7. Global Antihelminthics Sales Market Share by Manufacturers (2020-2025)
- Table 8. Global Antihelminthics Revenue of Manufacturers (2020-2025)
- Table 9. Global Antihelminthics Revenue Share by Manufacturers (2020-2025)
- Table 10. Global Market Antihelminthics Average Price (US$/Unit) of Manufacturers (2020-2025)
- Table 11. Global Antihelminthics Industry Ranking, 2023 VS 2024 VS 2025
- Table 12. Global Manufacturers of Antihelminthics, Manufacturing Sites & Headquarters
- Table 13. Global Manufacturers of Antihelminthics, Product Type & Application
- Table 14. Global Antihelminthics Manufacturers Established Date
- Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Antihelminthics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
- Table 18. Abbott Company Information
- Table 19. Abbott Business Overview
- Table 20. Abbott Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 21. Abbott Antihelminthics Product Portfolio
- Table 22. Abbott Recent Developments
- Table 23. Sanofi Company Information
- Table 24. Sanofi Business Overview
- Table 25. Sanofi Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 26. Sanofi Antihelminthics Product Portfolio
- Table 27. Sanofi Recent Developments
- Table 28. Sanofi Company Information
- Table 29. Sanofi Business Overview
- Table 30. Sanofi Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 31. Sanofi Antihelminthics Product Portfolio
- Table 32. Sanofi Recent Developments
- Table 33. Johnson & Johnson Company Information
- Table 34. Johnson & Johnson Business Overview
- Table 35. Johnson & Johnson Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 36. Johnson & Johnson Antihelminthics Product Portfolio
- Table 37. Johnson & Johnson Recent Developments
- Table 38. Novartis Company Information
- Table 39. Novartis Business Overview
- Table 40. Novartis Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 41. Novartis Antihelminthics Product Portfolio
- Table 42. Novartis Recent Developments
- Table 43. Pfizer Company Information
- Table 44. Pfizer Business Overview
- Table 45. Pfizer Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 46. Pfizer Antihelminthics Product Portfolio
- Table 47. Pfizer Recent Developments
- Table 48. GlaxoSmithKline Company Information
- Table 49. GlaxoSmithKline Business Overview
- Table 50. GlaxoSmithKline Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 51. GlaxoSmithKline Antihelminthics Product Portfolio
- Table 52. GlaxoSmithKline Recent Developments
- Table 53. Bayer Company Information
- Table 54. Bayer Business Overview
- Table 55. Bayer Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 56. Bayer Antihelminthics Product Portfolio
- Table 57. Bayer Recent Developments
- Table 58. AstraZeneca Company Information
- Table 59. AstraZeneca Business Overview
- Table 60. AstraZeneca Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 61. AstraZeneca Antihelminthics Product Portfolio
- Table 62. AstraZeneca Recent Developments
- Table 63. ZEISS International Company Information
- Table 64. ZEISS International Business Overview
- Table 65. ZEISS International Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 66. ZEISS International Antihelminthics Product Portfolio
- Table 67. ZEISS International Recent Developments
- Table 68. Merck & Co. Company Information
- Table 69. Merck & Co. Business Overview
- Table 70. Merck & Co. Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 71. Merck & Co. Antihelminthics Product Portfolio
- Table 72. Merck & Co. Recent Developments
- Table 73. Mentis Pharma Company Information
- Table 74. Mentis Pharma Business Overview
- Table 75. Mentis Pharma Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 76. Mentis Pharma Antihelminthics Product Portfolio
- Table 77. Mentis Pharma Recent Developments
- Table 78. Astellas Pharma Company Information
- Table 79. Astellas Pharma Business Overview
- Table 80. Astellas Pharma Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 81. Astellas Pharma Antihelminthics Product Portfolio
- Table 82. Astellas Pharma Recent Developments
- Table 83. ALLERGAN Company Information
- Table 84. ALLERGAN Business Overview
- Table 85. ALLERGAN Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 86. ALLERGAN Antihelminthics Product Portfolio
- Table 87. ALLERGAN Recent Developments
- Table 88. Global Antihelminthics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 89. Global Antihelminthics Sales by Region (2020-2025) & (K Units)
- Table 90. Global Antihelminthics Sales Market Share by Region (2020-2025)
- Table 91. Global Antihelminthics Sales by Region (2026-2031) & (K Units)
- Table 92. Global Antihelminthics Sales Market Share by Region (2026-2031)
- Table 93. Global Antihelminthics Revenue by Region (2020-2025) & (US$ Million)
- Table 94. Global Antihelminthics Revenue Market Share by Region (2020-2025)
- Table 95. Global Antihelminthics Revenue by Region (2026-2031) & (US$ Million)
- Table 96. Global Antihelminthics Revenue Market Share by Region (2026-2031)
- Table 97. North America Antihelminthics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 98. North America Antihelminthics Sales by Country (2020-2025) & (K Units)
- Table 99. North America Antihelminthics Sales by Country (2026-2031) & (K Units)
- Table 100. North America Antihelminthics Revenue by Country (2020-2025) & (US$ Million)
- Table 101. North America Antihelminthics Revenue by Country (2026-2031) & (US$ Million)
- Table 102. Europe Antihelminthics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 103. Europe Antihelminthics Sales by Country (2020-2025) & (K Units)
- Table 104. Europe Antihelminthics Sales by Country (2026-2031) & (K Units)
- Table 105. Europe Antihelminthics Revenue by Country (2020-2025) & (US$ Million)
- Table 106. Europe Antihelminthics Revenue by Country (2026-2031) & (US$ Million)
- Table 107. Asia Pacific Antihelminthics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 108. Asia Pacific Antihelminthics Sales by Country (2020-2025) & (K Units)
- Table 109. Asia Pacific Antihelminthics Sales by Country (2026-2031) & (K Units)
- Table 110. Asia Pacific Antihelminthics Revenue by Country (2020-2025) & (US$ Million)
- Table 111. Asia Pacific Antihelminthics Revenue by Country (2026-2031) & (US$ Million)
- Table 112. South America Antihelminthics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 113. South America Antihelminthics Sales by Country (2020-2025) & (K Units)
- Table 114. South America Antihelminthics Sales by Country (2026-2031) & (K Units)
- Table 115. South America Antihelminthics Revenue by Country (2020-2025) & (US$ Million)
- Table 116. South America Antihelminthics Revenue by Country (2026-2031) & (US$ Million)
- Table 117. Middle East and Africa Antihelminthics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 118. Middle East and Africa Antihelminthics Sales by Country (2020-2025) & (K Units)
- Table 119. Middle East and Africa Antihelminthics Sales by Country (2026-2031) & (K Units)
- Table 120. Middle East and Africa Antihelminthics Revenue by Country (2020-2025) & (US$ Million)
- Table 121. Middle East and Africa Antihelminthics Revenue by Country (2026-2031) & (US$ Million)
- Table 122. Global Antihelminthics Sales by Type (2020-2025) & (K Units)
- Table 123. Global Antihelminthics Sales by Type (2026-2031) & (K Units)
- Table 124. Global Antihelminthics Sales Market Share by Type (2020-2025)
- Table 125. Global Antihelminthics Sales Market Share by Type (2026-2031)
- Table 126. Global Antihelminthics Revenue by Type (2020-2025) & (US$ Million)
- Table 127. Global Antihelminthics Revenue by Type (2026-2031) & (US$ Million)
- Table 128. Global Antihelminthics Revenue Market Share by Type (2020-2025)
- Table 129. Global Antihelminthics Revenue Market Share by Type (2026-2031)
- Table 130. Global Antihelminthics Price by Type (2020-2025) & (US$/Unit)
- Table 131. Global Antihelminthics Price by Type (2026-2031) & (US$/Unit)
- Table 132. Global Antihelminthics Sales by Application (2020-2025) & (K Units)
- Table 133. Global Antihelminthics Sales by Application (2026-2031) & (K Units)
- Table 134. Global Antihelminthics Sales Market Share by Application (2020-2025)
- Table 135. Global Antihelminthics Sales Market Share by Application (2026-2031)
- Table 136. Global Antihelminthics Revenue by Application (2020-2025) & (US$ Million)
- Table 137. Global Antihelminthics Revenue by Application (2026-2031) & (US$ Million)
- Table 138. Global Antihelminthics Revenue Market Share by Application (2020-2025)
- Table 139. Global Antihelminthics Revenue Market Share by Application (2026-2031)
- Table 140. Global Antihelminthics Price by Application (2020-2025) & (US$/Unit)
- Table 141. Global Antihelminthics Price by Application (2026-2031) & (US$/Unit)
- Table 142. Key Raw Materials
- Table 143. Raw Materials Key Suppliers
- Table 144. Antihelminthics Distributors List
- Table 145. Antihelminthics Customers List
- Table 146. Antihelminthics Industry Trends
- Table 147. Antihelminthics Industry Drivers
- Table 148. Antihelminthics Industry Restraints
- Table 149. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Antihelminthics Product Image
- Figure 5. Global Antihelminthics Revenue (US$ Million), 2020 VS 2024 VS 2031
- Figure 6. Global Antihelminthics Market Size (2020-2031) & (US$ Million)
- Figure 7. Global Antihelminthics Sales (2020-2031) & (K Units)
- Figure 8. Global Antihelminthics Average Price (US$/Unit) & (2020-2031)
- Figure 9. Salicylanilides Product Image
- Figure 10. Benzimidazoles Product Image
- Figure 11. Praziquantel Product Image
- Figure 12. Abamectin Product Image
- Figure 13. Other Product Image
- Figure 14. Ascariasis Product Image
- Figure 15. Giardiasis Product Image
- Figure 16. Fasciolasis Product Image
- Figure 17. Filariasis Product Image
- Figure 18. Angiostrongylosis Product Image
- Figure 19. Schistosomiasis Product Image
- Figure 20. Other Product Image
- Figure 21. Global Antihelminthics Revenue Share by Manufacturers in 2024
- Figure 22. Global Manufacturers of Antihelminthics, Manufacturing Sites & Headquarters
- Figure 23. Global Top 5 and 10 Antihelminthics Players Market Share by Revenue in 2024
- Figure 24. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 25. Global Antihelminthics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Figure 26. Global Antihelminthics Sales by Region in 2024
- Figure 27. Global Antihelminthics Revenue by Region in 2024
- Figure 28. North America Antihelminthics Market Size by Country in 2024
- Figure 29. North America Antihelminthics Sales Market Share by Country (2020-2031)
- Figure 30. North America Antihelminthics Revenue Market Share by Country (2020-2031)
- Figure 31. United States Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 32. Canada Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 33. Europe Antihelminthics Market Size by Country in 2024
- Figure 34. Europe Antihelminthics Sales Market Share by Country (2020-2031)
- Figure 35. Europe Antihelminthics Revenue Market Share by Country (2020-2031)
- Figure 36. Germany Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 37. France Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 38. U.K. Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 39. Italy Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 40. Netherlands Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 41. Nordic Countries Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 42. Asia Pacific Antihelminthics Market Size by Country in 2024
- Figure 43. Asia Pacific Antihelminthics Sales Market Share by Country (2020-2031)
- Figure 44. Asia Pacific Antihelminthics Revenue Market Share by Country (2020-2031)
- Figure 45. China Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 46. Japan Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 47. South Korea Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 48. India Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 49. Australia Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 50. China Taiwan Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 51. Southeast Asia Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 52. Southeast Asia Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 53. South America Antihelminthics Market Size by Country in 2024
- Figure 54. South America Antihelminthics Sales Market Share by Country (2020-2031)
- Figure 55. South America Antihelminthics Revenue Market Share by Country (2020-2031)
- Figure 56. Mexico Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 57. Brazil Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 58. Argentina Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 59. Middle East and Africa Antihelminthics Market Size by Country in 2024
- Figure 60. Middle East and Africa Antihelminthics Sales Market Share by Country (2020-2031)
- Figure 61. Middle East and Africa Antihelminthics Revenue Market Share by Country (2020-2031)
- Figure 62. Turkey Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 63. Saudi Arabia Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 64. UAE Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 65. Global Antihelminthics Sales Market Share by Type (2020-2031)
- Figure 66. Global Antihelminthics Revenue Market Share by Type (2020-2031)
- Figure 67. Global Antihelminthics Price (US$/Unit) by Type (2020-2031)
- Figure 68. Global Antihelminthics Sales Market Share by Application (2020-2031)
- Figure 69. Global Antihelminthics Revenue Market Share by Application (2020-2031)
- Figure 70. Global Antihelminthics Price (US$/Unit) by Application (2020-2031)
- Figure 71. Antihelminthics Value Chain
- Figure 72. Antihelminthics Production Mode & Process
- Figure 73. Direct Comparison with Distribution Share
- Figure 74. Distributors Profiles
- Figure 75. Antihelminthics Industry Opportunities and Challenges
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


